329 related articles for article (PubMed ID: 10898980)
21. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding.
Hymowitz SG; Patel DR; Wallweber HJ; Runyon S; Yan M; Yin J; Shriver SK; Gordon NC; Pan B; Skelton NJ; Kelley RF; Starovasnik MA
J Biol Chem; 2005 Feb; 280(8):7218-27. PubMed ID: 15542592
[TBL] [Abstract][Full Text] [Related]
22. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.
Thompson JS; Bixler SA; Qian F; Vora K; Scott ML; Cachero TG; Hession C; Schneider P; Sizing ID; Mullen C; Strauch K; Zafari M; Benjamin CD; Tschopp J; Browning JL; Ambrose C
Science; 2001 Sep; 293(5537):2108-11. PubMed ID: 11509692
[TBL] [Abstract][Full Text] [Related]
23. The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
Lyu MA; Cheung LH; Hittelman WN; Marks JW; Aguiar RC; Rosenblum MG
Mol Cancer Ther; 2007 Feb; 6(2):460-70. PubMed ID: 17267661
[TBL] [Abstract][Full Text] [Related]
24. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
Kayagaki N; Yan M; Seshasayee D; Wang H; Lee W; French DM; Grewal IS; Cochran AG; Gordon NC; Yin J; Starovasnik MA; Dixit VM
Immunity; 2002 Oct; 17(4):515-24. PubMed ID: 12387744
[TBL] [Abstract][Full Text] [Related]
25. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.
Novak AJ; Darce JR; Arendt BK; Harder B; Henderson K; Kindsvogel W; Gross JA; Greipp PR; Jelinek DF
Blood; 2004 Jan; 103(2):689-94. PubMed ID: 14512299
[TBL] [Abstract][Full Text] [Related]
26. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
[TBL] [Abstract][Full Text] [Related]
27. Activation and accumulation of B cells in TACI-deficient mice.
Yan M; Wang H; Chan B; Roose-Girma M; Erickson S; Baker T; Tumas D; Grewal IS; Dixit VM
Nat Immunol; 2001 Jul; 2(7):638-43. PubMed ID: 11429549
[TBL] [Abstract][Full Text] [Related]
28. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency.
Salzer U; Grimbacher B
Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):496-503. PubMed ID: 16264328
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of BLyS action in B cell immunity.
Do RK; Chen-Kiang S
Cytokine Growth Factor Rev; 2002 Feb; 13(1):19-25. PubMed ID: 11750877
[TBL] [Abstract][Full Text] [Related]
30. Engineering an APRIL-specific B cell maturation antigen.
Patel DR; Wallweber HJ; Yin J; Shriver SK; Marsters SA; Gordon NC; Starovasnik MA; Kelley RF
J Biol Chem; 2004 Apr; 279(16):16727-35. PubMed ID: 14764606
[TBL] [Abstract][Full Text] [Related]
31. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
[TBL] [Abstract][Full Text] [Related]
32. Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.
Yaccoby S; Pennisi A; Li X; Dillon SR; Zhan F; Barlogie B; Shaughnessy JD
Leukemia; 2008 Feb; 22(2):406-13. PubMed ID: 18046446
[TBL] [Abstract][Full Text] [Related]
33. TACI and BAFF-R mediate isotype switching in B cells.
Castigli E; Wilson SA; Scott S; Dedeoglu F; Xu S; Lam KP; Bram RJ; Jabara H; Geha RS
J Exp Med; 2005 Jan; 201(1):35-9. PubMed ID: 15630136
[TBL] [Abstract][Full Text] [Related]
34. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
[TBL] [Abstract][Full Text] [Related]
35. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells.
Yang M; Hase H; Legarda-Addison D; Varughese L; Seed B; Ting AT
J Immunol; 2005 Sep; 175(5):2814-24. PubMed ID: 16116167
[TBL] [Abstract][Full Text] [Related]
36. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
37. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
[TBL] [Abstract][Full Text] [Related]
38. BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.
Pelekanou V; Notas G; Kampa M; Tsentelierou E; Stathopoulos EN; Tsapis A; Castanas E
PLoS One; 2013; 8(12):e83250. PubMed ID: 24376672
[TBL] [Abstract][Full Text] [Related]
39. BLyS and APRIL in rheumatoid arthritis.
Seyler TM; Park YW; Takemura S; Bram RJ; Kurtin PJ; Goronzy JJ; Weyand CM
J Clin Invest; 2005 Nov; 115(11):3083-92. PubMed ID: 16239971
[TBL] [Abstract][Full Text] [Related]
40. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1.
Xu LG; Wu M; Hu J; Zhai Z; Shu HB
J Leukoc Biol; 2002 Aug; 72(2):410-6. PubMed ID: 12149433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
